GNVC Share Price

Open 7.21 Change Price %
High 7.25 1 Day -0.02 -0.28
Low 7.01 1 Week 0.00 0.00
Close 7.19 1 Month 0.00 0.00
Volume 12934 1 Year 6.81 1792.11
52 Week High 10.44
52 Week Low 0.27
GNVC Important Levels
Resistance 2 7.41
Resistance 1 7.32
Pivot 7.15
Support 1 7.06
Support 2 6.97
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
ASTI 0.00 0.00%
More..
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
DCTH 0.04 33.33%
RITT 0.04 33.33%
SCHS 0.04 33.33%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
NEXS 0.05 25.00%
PRAN 3.25 24.52%
PGRX 0.06 20.00%
More..
NASDAQ USA Top Losers Stocks
CAFI 0.00 -100.00%
LIWA 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.01 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
More..

GenVec, Inc. (NASDAQ: GNVC)

GNVC Technical Analysis 4
As on 15th Jun 2017 GNVC Share Price closed @ 7.19 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 3.60 & Buy for SHORT-TERM with Stoploss of 6.48 we also expect STOCK to react on Following IMPORTANT LEVELS.
GNVC Target for October
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
GNVC Other Details
Segment EQ
Market Capital 18522088.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.genvec.com
GNVC Address
GNVC
910 Clopper Road
Suite 220N
Gaithersburg, MD 20878
United States
Phone: 240-632-0740
Fax: 240-632-0735
GNVC Latest News
Interactive Technical Analysis Chart GenVec, Inc. ( GNVC NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on GenVec, Inc.
GNVC Business Profile
GenVec, Inc. develops gene-based pharmaceuticals and therapies for the treatment of major medical needs. The Company combines its patented gene transfer technologies with proprietary therapeutic genes to create product candidates that address needs in the areas of cardiovascular disease, cancer and other therapeutic areas.